Entasis Therapeutics Holdings Inc.
ETTX
ETTX was delisted on the 8th of July, 2022.
20 hedge funds and large institutions have $21.8M invested in Entasis Therapeutics Holdings Inc. in 2020 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
11% more funds holding
Funds holding: 18 → 20 (+2)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
49% less capital invested
Capital invested by funds: $42.5M → $21.8M (-$20.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$158K |
| 2 |
Renaissance Technologies
New York
|
+$44.2K |
| 3 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
+$15.3K |
| 4 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$9.01K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$2.69K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FM
Frazier Management
Seattle,
Washington
|
-$1.35M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$12.2K |
| 3 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$10.3K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$6.68K |
| 5 |
BlackRock
New York
|
-$3.33K |
ETTX Hedge Fund Activity: Q1 2020 in Review
20 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Entasis Therapeutics Holdings Inc. (ETTX) for Q1 2020, worth a combined $21.8M — down 49% from $42.5M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new ETTX positions and 1 closed out — a net gain of 2 holders — while 4 added to existing stakes and 5 trimmed.
The largest buyer was Bridgeway Capital Management, opening a new position worth an estimated $158K. The largest seller was Frazier Management, cutting an estimated $1.35M.
- 20 institutional investors held Entasis Therapeutics Holdings Inc. (ETTX) as of Q1 2020, up from 18 in Q4 2019.
- Funds reported $21.8M of Entasis Therapeutics Holdings Inc. stock for Q1 2020, down 49% quarter-over-quarter.
- 3 funds opened new Entasis Therapeutics Holdings Inc. positions in Q1 2020 and 1 closed out, a net change of +2 holders.
- The largest Entasis Therapeutics Holdings Inc. buyer in Q1 2020 was Bridgeway Capital Management, an estimated $158K added.
- The largest Entasis Therapeutics Holdings Inc. seller in Q1 2020 was Frazier Management, an estimated $1.35M sold.
Based on aggregated 13F filings for Q1 2020.